GnRH Antagonist Pre-treatment in the Early Follicular Phase for Resolution of a Baseline Functional Ovarian Cyst
Status:
Recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
In this study we would like to examine the effect of GnRH antagonist administration at the
beginning of the follicular phase in patient presenting with a simple ovarian cyst 25-50 mm.
The aim of this intervention is to allow a spontaneous regression of the ovarian cyst (if in
nature) while ensuring a pituitary downregulation to prevent the beginning of a leading
follicle recruitment. As previous studies using GnRH antagonist pre-treatment prior to GT
initiation for other purposes demonstrated positive results (including different patient
population) , no deleterious effects are expected.